Your browser doesn't support javascript.
loading
Description of late onset neutropenia in indolent lymphoma patients treated with bendamustine plus rituximab.
Verriere, B; Gastaud, L; Chamorey, E; Peyrade, F; Deletie, E; Bouredji, K; Quinsat, D; Schiappa, R; Thyss, A; Re, D.
Afiliação
  • Verriere B; Pharmacy department, Antibes Hospital, Antibes, France.
  • Gastaud L; Oncology department, Anticancer Center Antoine Lacassagne, Nice, France.
  • Chamorey E; Biostatistics and epidemiology department, Anticancer Center Antoine Lacassagne, Nice, France.
  • Peyrade F; Oncology department, Anticancer Center Antoine Lacassagne, Nice, France.
  • Deletie E; Pharmacy department, Antibes Hospital, Antibes, France.
  • Bouredji K; Oncology and hemato oncology department, Antibes Hospital, Antibes, France.
  • Quinsat D; Internal Medicine department, Antibes Hospital, Antibes, France.
  • Schiappa R; Biostatistics and epidemiology department, Anticancer Center Antoine Lacassagne, Nice, France.
  • Thyss A; Oncology department, Anticancer Center Antoine Lacassagne, Nice, France.
  • Re D; Oncology department, Anticancer Center Antoine Lacassagne, Nice, France.
Hematol Oncol ; 36(1): 144-149, 2018 Feb.
Article em En | MEDLINE | ID: mdl-28685846
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cloridrato de Bendamustina / Rituximab / Antineoplásicos Imunológicos / Linfoma Idioma: En Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Cloridrato de Bendamustina / Rituximab / Antineoplásicos Imunológicos / Linfoma Idioma: En Ano de publicação: 2018 Tipo de documento: Article